MediWound Ltd. (MDWD)
Total Valuation
MediWound has a market cap or net worth of $57.66 million. The enterprise value is $42.07 million.
Market Cap | 57.66M |
Enterprise Value | 42.07M |
Important Dates
The latest earnings date was Tuesday, May 17, 2022, before market open.
Last Earnings Date | May 17, 2022 |
Ex-Dividend Date | n/a |
Share Statistics
MediWound has 33.14 million shares outstanding. The number of shares has increased by 5.49% in one year.
Shares Outstanding | 33.14M |
Shares Change (YoY) | +5.49% |
Shares Change (QoQ) | +5.45% |
Owned by Insiders (%) | 40.40% |
Owned by Institutions (%) | 8.55% |
Float | 17.13M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.58 |
PB Ratio | 29.65 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.88 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.64.
Current Ratio | 1.95 |
Quick Ratio | 1.80 |
Debt / Equity | 0.64 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -59.90% |
Return on Capital (ROIC) | -493,080.00% |
Revenue Per Employee | $289,909 |
Profits Per Employee | -$185,571 |
Employee Count | 77 |
Asset Turnover | 0.94 |
Inventory Turnover | 8.56 |
Taxes
In the past 12 months, MediWound has paid $31,000 in taxes.
Income Tax | 31,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.05% in the last 52 weeks. The beta is 1.40, so MediWound's price volatility has been higher than the market average.
Beta (1Y) | 1.40 |
52-Week Price Change | -56.05% |
50-Day Moving Average | 2.01 |
200-Day Moving Average | 2.32 |
Average Volume (30 Days) | 117,422 |
Short Selling Information
The latest short interest is 42,404, so 0.13% of the outstanding shares have been sold short.
Short Interest | 42,404 |
Short % of Shares Out | 0.13% |
Short % of Float | 0.25% |
Short Ratio (days to cover) | 0.64 |
Income Statement
In the last 12 months, MediWound had revenue of $22.32 million and -14.29 million in losses. Earnings per share was -$0.52.
Revenue | 22.32M |
Gross Profit | 7.82M |
Operating Income | -12.58M |
Pretax Income | -14.26M |
Net Income | -14.29M |
EBITDA | -11.08M |
EBIT | -12.33M |
Earnings Per Share (EPS) | -$0.52 |
Balance Sheet
The company has $16.84 million in cash and $1.24 million in debt, giving a net cash position of $15.60 million or $0.47 per share.
Cash & Cash Equivalents | 16.84M |
Total Debt | 1.24M |
Net Cash | 15.60M |
Net Cash Per Share | $0.47 |
Book Value | 1.95M |
Book Value Per Share | 0.06 |
Working Capital | 10.71M |
Cash Flow
In the last 12 months, operating cash flow was -$10.10 million and capital expenditures -$431,000, giving a free cash flow of -$10.53 million.
Operating Cash Flow | -10.10M |
Capital Expenditures | -431,000 |
Free Cash Flow | -10.53M |
FCF Per Share | n/a |
Margins
Gross margin is 35.01%, with operating and profit margins of -56.37% and -64.01%.
Gross Margin | 35.01% |
Operating Margin | -56.37% |
Pretax Margin | -63.87% |
Profit Margin | -64.01% |
EBITDA Margin | -49.62% |
EBIT Margin | -55.22% |
FCF Margin | -47.19% |
Dividends & Yields
MediWound does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -24.78% |
FCF Yield | -18.27% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Analyst Forecast
The average price target for MediWound is $6.38, which is 266.67% higher than the current price. The consensus rating is "Buy".
Price Target | $6.38 |
Price Target Difference | 266.67% |
Analyst Consensus | Buy |
Analyst Count | 12 |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |